Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2792)
All Articles published online
|
Jul 14, 2008 (publication date) through May 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Freeman HJ. Use of the Crohn’s disease activity index in clinical trials of biological agents. World J Gastroenterol 2008; 14(26): 4127-4130 [PMID: 18636655 DOI: 10.3748/wjg.14.4127] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i26/4127.htm |
| Number | Citing Articles |
| 1 |
John R. Leyendecker, Richard S. Bloomfeld, David J. DiSantis, Gregory S. Waters, Ryan Mott, Robert E. Bechtold. MR Enterography in the Management of Patients with Crohn Disease. RadioGraphics 2009; 29(6): 1827 doi: 10.1148/rg.296095510
|
| 2 |
Marte Lie Høivik, Tomm Bernklev, Inger Camilla Solberg, Milada Cvancarova, Idar Lygren, Jørgen Jahnsen, Bjørn Moum. Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study. Journal of Crohn's and Colitis 2012; 6(4): 441 doi: 10.1016/j.crohns.2011.10.001
|
| 3 |
Jamilya Kaibullayeva, Aliya Ualiyeva, Ainash Oshibayeva, Anar Dushpanova, John K. Marshall. Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study. Intestinal Research 2020; 18(4): 430 doi: 10.5217/ir.2019.00099
|
| 4 |
Hemanth Veluswamy, Kunal Suryawala, Ankur Sheth, Shannon Wells, Erik Salvatierra, Walter Cromer, Ganta V Chaitanya, Annette Painter, Mihir Patel, Kenneth Manas, Ellenmarie Zwank, Moheb Boktor, Kondal Baig, Balaji Datti, Michael J Mathis, Alireza Minagar, Paul A Jordan, Jonathan S Alexander. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-104
|
| 5 |
Lian-Ming Wu, Jian-Rong Xu, Hai-Yan Gu, Jia Hua, Jiani Hu. Is Magnetic Resonance Imaging a Reliable Diagnostic Tool in the Evaluation of Active Crohn’s Disease in the Small Bowel?. Journal of Clinical Gastroenterology 2013; 47(4): 328 doi: 10.1097/MCG.0b013e31825d5034
|
| 6 |
Sarah Alrubia, Jialin Mao, Yuan Chen, Jill Barber, Amin Rostami-Hodjegan. Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs. Clinical Pharmacokinetics 2022; 61(10): 1365 doi: 10.1007/s40262-022-01169-4
|
| 7 |
Silvio Mazziotti, Giorgio Ascenti, Emanuele Scribano, Michele Gaeta, Alessia Pandolfo, Francesco Bombaci, Rocco Donato, Walter Fries, Alfredo Blandino. Guide to magnetic resonance in Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(5): 1209 doi: 10.1002/ibd.21548
|
| 8 |
Rebecca Williams-Hall, Claire Trennery, Kate Sully, Samantha Wratten, Anya Francis, Dale Chandler, Jessica Flynn, Megan Turner, Daniel J. B. Marks, Alfred Sackeyfio, Marguerite Bracher, Alex Walker, Louise Walker-Nthenda, Rob Arbuckle, Tom Keeley. A qualitative study to explore the symptoms and impacts of Crohn’s disease and to develop the Crohn’s Disease Diary. Quality of Life Research 2023; 32(1): 209 doi: 10.1007/s11136-022-03233-9
|
| 9 |
Eva Beňová, Mária Boledovičová, Erika Krištofová, Ľuboslava Pavelová. Nutrition interventions in patients with Crohn´s disease. Potravinarstvo Slovak Journal of Food Sciences 2016; 10(1): 481 doi: 10.5219/650
|
| 10 |
Gabriela Schill, Igors Iesalnieks, Michael Haimerl, René Müller-Wille, Lena-Marie Dendl, Philipp Wiggermann, Stephan Schleder, Janine Rennert, Claudia Ott, Ayman Agha, Christian Stroszczynski, Andreas G. Schreyer. Assessment of Disease Behavior in Patients with Crohn’s Disease by MR Enterography. Inflammatory Bowel Diseases 2013; 19(5): 983 doi: 10.1097/MIB.0b013e31828029dd
|
| 11 |
Petra Baji, László Gulácsi, Barbara D. Lovász, Petra A. Golovics, Valentin Brodszky, Márta Péntek, Fanni Rencz, Péter L. Lakatos. Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists. Scandinavian Journal of Gastroenterology 2016; 51(1): 22 doi: 10.3109/00365521.2015.1054422
|
| 12 |
Anna La Noce, Marcin Ernst. Editor’s Pick: Identifying Shared Features and Addressing Common Challenges in Clinical Trials for Chronic Inflammatory Diseases: An Overview. European Medical Journal 2019; : 45 doi: 10.33590/emj/10310605
|
| 13 |
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, Heda Amarante, Pal Miheller, Brian Feagan, Geert D'Haens, Philippe Marteau, Walter Reinisch, Andreas Sturm, Flavio Steinwurz, Laurence Egan, Julián Panés, Edouard Louis, Jean-Frédéric Colombel, Remo Panaccione. Optimising monitoring in the management of Crohn's disease: A physician's perspective. Journal of Crohn's and Colitis 2013; 7(8): 653 doi: 10.1016/j.crohns.2013.02.005
|
| 14 |
Thais Guaraná Andrade, Homero Soares Fogaça, Celeste Carvalho Siqueira Elia, Melissa Tassano Pitrowsky, Heitor Siffert Pereira de Souza. Crohn's disease activity assessed by doppler sonography: the role of aortic flow parameters. Clinics 2013; 68(4): 457 doi: 10.6061/clinics/2013(04)04
|
| 15 |
Jiahong Li, Xiaohua Pan, Zhengnan Ren, Binbin Li, He Liu, Chengfei Wu, Xiaoliang Dong, Paul de Vos, Li‐Long Pan, Jia Sun. Protein arginine methyltransferase 2 (PRMT2) promotes dextran sulfate sodium‐induced colitis by inhibiting the SOCS3 promoter via histone H3R8 asymmetric dimethylation. British Journal of Pharmacology 2022; 179(1): 141 doi: 10.1111/bph.15695
|
| 16 |
Bamidele Johnson Alegbeleye. Crohn’s disease in a developing African mission hospital: a case report. Journal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-1971-5
|
| 17 |
Hala Elzayat, Talha Malik, Haifa Al-Awadhi, Mazen Taha, Gehad Elghazali, Farah Al-Marzooq. Deciphering salivary microbiome signature in Crohn’s disease patients with different factors contributing to dysbiosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46714-8
|
| 18 |
Lucrezia Laterza, Anna Chiara Piscaglia, Laura Maria Minordi, Iolanda Scoleri, Luigi Larosa, Andrea Poscia, Fabio Ingravalle, Arianna Amato, Sergio Alfieri, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Franco Scaldaferri. Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease. Digestive Diseases 2018; 36(3): 184 doi: 10.1159/000487589
|
| 19 |
Hussam Murad, Misbahuddin Rafeeq, Mahmoud Mosli, Mamdouh Gari, Mohammed Basheikh. Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with Helicobacter pylori infection and co-existing inflammatory bowel disease. Journal of International Medical Research 2021; 49(11): 030006052110606 doi: 10.1177/03000605211060648
|
| 20 |
Alexander Tsertsvadze, Tara Gurung, Rachel Court, Aileen Clarke, Paul Sutcliffe. Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn’s disease: a systematic review and meta-analysis. Health Technology Assessment 2015; 19(26): 1 doi: 10.3310/hta19260
|
| 21 |
Ana Maria Oliveira, Filipe Sousa Cardoso, Catarina Graça Rodrigues, Liliana Santos, Alexandra Martins, João Ramos de Deus, Jorge Reis. Can Red Cell Distribution Width Be Used as a Marker of Crohn's Disease Activity?. GE Portuguese Journal of Gastroenterology 2016; 23(1): 6 doi: 10.1016/j.jpge.2015.10.003
|
| 22 |
Hye Kyung Hyun, Jongwook Yu, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon. Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement. The Korean Journal of Internal Medicine 2022; 37(3): 567 doi: 10.3904/kjim.2021.233
|
| 23 |
L. Quenon, P. Hindryckx, M. De Vos, D. De Looze, G. Joos, G. Brusselle, H. Peeters. Hand-held fractional exhaled nitric oxide measurements as a non-invasive indicator of systemic inflammation in Crohn's disease. Journal of Crohn's and Colitis 2013; 7(8): 644 doi: 10.1016/j.crohns.2012.09.021
|
| 24 |
Müjgan GÜRLER, Güray CAN, Hatice CAN, Hüseyin Ahmet TEZEL, Gülbin ÜNSAL, Ali Rıza SOYLU, Hasan Celalettin ÜMİT, Meral AKDOĞAN KAYHAN. The relationship between hematological parameters and disease activity in İnflammatory bowel disease. Anadolu Güncel Tıp Dergisi 2020; doi: 10.38053/acmj.724021
|
| 25 |
Silvio Danese, Elmer Schabel, Mark Andrew Ainsworth, Laurent Peyrin-Biroulet. Challenges and opportunities for IBD drug development: from early stage to regulatory approval. Gut 2020; 69(7): 1157 doi: 10.1136/gutjnl-2019-320542
|
| 26 |
D. Achitei, A. Ciobica, G. Balan, E. Gologan, C. Stanciu, G. Stefanescu. Different Profile of Peripheral Antioxidant Enzymes and Lipid Peroxidation in Active and Non-active Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 2013; 58(5): 1244 doi: 10.1007/s10620-012-2510-z
|
| 27 |
Lindsay Hahn, Ashton Beggs, Kristy Wahaib, Leela Kodali, Vanessa Kirkwood. Vedolizumab: An integrin-receptor antagonist for treatment of Crohn’s disease and ulcerative colitis. American Journal of Health-System Pharmacy 2015; 72(15): 1271 doi: 10.2146/ajhp140449
|
| 28 |
David H. Bruining, Edward V. Loftus, Eric C. Ehman, Hassan A. Siddiki, Douglas L. Nguyen, Jeff L. Fidler, James E. Huprich, Jayawant N. Mandrekar, William S. Harmsen, William J. Sandborn, Joel G. Fletcher. Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology 2011; 9(8): 679 doi: 10.1016/j.cgh.2011.04.025
|
| 29 |
Olwen Westerland, Nyree Griffin. Magnetic Resonance Enterography in Crohn׳s Disease. Seminars in Ultrasound, CT and MRI 2016; 37(4): 282 doi: 10.1053/j.sult.2016.02.001
|
| 30 |
Darko Brnić, Dinko Martinovic, Piero Marin Zivkovic, Daria Tokic, Ivana Tadin Hadjina, Doris Rusic, Marino Vilovic, Daniela Supe-Domic, Ante Tonkic, Josko Bozic. Serum adropin levels are reduced in patients with inflammatory bowel diseases. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66254-9
|
| 31 |
Paulina Horwat, Stanisław Kopeć, Aleksandra Garczyk, Iwona Kaliciak, Zuzanna Staręga, Konstanty Drogowski, Marcin Mardas, Marta Stelmach-Mardas. Influence of Enteral Nutrition on Gut Microbiota Composition in Patients with Crohn’s Disease: A Systematic Review. Nutrients 2020; 12(9): 2551 doi: 10.3390/nu12092551
|
| 32 |
Stephen Hanauer, Bernd Liedert, Sigrid Balser, Ekkehard Brockstedt, Viktoria Moschetti, Stefan Schreiber. Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial. The Lancet Gastroenterology & Hepatology 2021; 6(10): 816 doi: 10.1016/S2468-1253(21)00252-1
|
| 33 |
Yan Xu, Aditi Sharma, Yang Chen, Honghui Zhou. What We Can Learn from Current Inflammatory Bowel Disease (IBD) Biological Therapy—Dose Regimen and Others. Current Pharmacology Reports 2019; 5(3): 115 doi: 10.1007/s40495-019-00180-x
|
| 34 |
Maximilian Thormann, Bohdan Melekh, Caroline Bär, Maciej Pech, Jazan Omari, Andreas Wienke, Hans-Jonas Meyer, Alexey Surov. Apparent diffusion coefficient for assessing Crohn’s disease activity: a meta-analysis. European Radiology 2022; 33(3): 1677 doi: 10.1007/s00330-022-09149-9
|
| 35 |
Thomas X. Lu, Russell D. Cohen. Maneuvering Clinical Pathways for Crohn’s Disease. Current Gastroenterology Reports 2019; 21(5) doi: 10.1007/s11894-019-0687-4
|
| 36 |
Satoshi Serada, Minoru Fujimoto, Fumitaka Terabe, Hideki Iijima, Shinichiro Shinzaki, Shinya Matsuzaki, Tomoharu Ohkawara, Riichiro Nezu, Sachiko Nakajima, Taku Kobayashi, Scott Eric Plevy, Tetsuo Takehara, Tetsuji Naka. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflammatory Bowel Diseases 2012; 18(11): 2169 doi: 10.1002/ibd.22936
|
| 37 |
Pegah Hosseini-Carroll, Monica Mutyala, Abhishek Seth, Shaheen Nageeb, Demiana Soliman, Moheb Boktor, Ankur Sheth, Jonathon Chapman, James Morris, Paul Jordan, Kenneth Manas, Felix Becker, Jonathan Steven Alexander. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 156-171 doi: 10.4292/wjgpt.v6.i4.156
|
| 38 |
Byong Duk Ye, Marina Pesegova, Olga Alexeeva, Marina Osipenko, Adi Lahat, Andriy Dorofeyev, Sigal Fishman, Olena Levchenko, Jae Hee Cheon, Maria Lia Scribano, Radu-Bogdan Mateescu, Kang-Moon Lee, Chang Soo Eun, Sang Joon Lee, Sung Young Lee, HoUng Kim, Stefan Schreiber, Heather Fowler, Raymond Cheung, Young-Ho Kim. Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study. The Lancet 2019; 393(10182): 1699 doi: 10.1016/S0140-6736(18)32196-2
|
| 39 |
Danielle Cohen, Ceres Maltz Bin, Ana Paula Trussardi Fayh. Assessment of quality of life of patients with inflammatory bowel disease residing in Southern Brazil. Arquivos de Gastroenterologia 2010; 47(3): 285 doi: 10.1590/S0004-28032010000300014
|
| 40 |
Ramandeep Singh, Rubal Rai, Nayla Mroueh, Avinash Kambadakone. Role of Dual Energy Computed Tomography in Inflammatory Bowel Disease. Seminars in Ultrasound, CT and MRI 2022; 43(4): 320 doi: 10.1053/j.sult.2022.03.008
|